| ACAT | Acyl CoA cholesterol acyltransferase |
| AhR | Aryl hydrocarbon receptor |
| ALD | Alcoholic liver disease |
| AMPK | AMP-activated protein kinase |
| ASBT | Apical sodium-dependent bile-salt transporter |
| BA | Bile acid |
| BAT | Brown adipose tissue |
| CAZymes | Carbohydrate active enzyme |
| CPT1 | Carnitine palmitoyl transferase 1 |
| C/EBP | CCAAT/enhancer binding protein |
| Cyp | Cytochrome P450 |
| DC | Dendritic cell |
| FAO | Fatty acid oxidation |
| FFAR | Free fatty acid receptor |
| FGF | Fibroblast growth factor |
| FXR | Farnesoid X receptor |
| GalA | Galacturonic acid |
| GLP-1 | Glucagon-like peptide 1 |
| GPCR | G-protein coupled receptor |
| GPR | G-protein coupled receptor |
| Glut | Glucose transporter |
| HAT | Histone acetyl transferase |
| HCAR | Hydroxycarboxylic acid receptor |
| HCC | Hepatocellular carcinoma |
| HDAC | Histone deacetylase |
| HFD | High-fat diet |
| HMGCoA | Hydroxy-methylglutaryl coenzyme A |
| HOMA-IR | Homeostatic model assessment for insulin resistance |
| ILC | Innate lymphoid cell |
| IM | Intestinal microbiota |
| IRS-1 | Insulin receptor substrate-1 |
| LDL | Low-density lipoprotein |
| MAFLD | Metabolic-associated fatty liver disease |
| MO | Macrophage |
| MUFA | Mono-unsaturated fatty acid |
| NAFLD | Non-alcoholic fatty liver disease |
| NASH | Non-alcoholic steatohepatitis |
| PD1 | Programmed cell death protein 1 |
| PPAR | Peroxisome proliferator-activated receptor |
| PUFA | Poly-unsaturated fatty acid |
| PYY | Peptide YY |
| SCFA | Short-chain fatty acids |
| sAH | Severe alcoholic hepatitis |
| SFA | Saturated fatty acid |
| RG | Rhamnogalacturonan |
| TBA | Total bile acids |
| TG | Triglycerides |
| TGR5 | Takeda G-protein-coupled receptors |
| TLR | Toll-like receptor |
| Treg | Lymphocyte T regulator |
| TUDCA | Tauro-ursodeoxycholic acid |
| UCP1 | Uncoupling protein 1 |
| UDCA | Ursodeoxycholic acid |
| WAT | White adipose tissue |
| WT | Wild-type |